🇺🇸 FDA
Patent

US 10406225

Anti-EphA2 antibodies and methods of use thereof

granted A61KA61K39/39558A61K47/60

Quick answer

US patent 10406225 (Anti-EphA2 antibodies and methods of use thereof) held by The Regents of the University of California expires Mon Sep 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Sep 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61K, A61K39/39558, A61K47/60, A61P, A61P35/00